Join | Donations | Contact Us | Print Page | Sign In
Her Heart Matters: Preventing, Diagnosing and Treating HF in Women
Tell a Friend About This EventTell a Friend

Take the Quiz

10/31/2017 to 10/31/2018
When: October 2016 - October 2018
Where: Online Educational Activity
United States
Contact: Gail Haas

Online registration is closed.
« Go to Upcoming Event List  

Her Heart Matters: Preventing, Diagnosing and Treating HF in Women       

Enduring Activity

Expiration Date:October 2018

1.75 Contact Hour ANCC


View Content

Purpose Statement

Heart failure (HF) is increasing in incidence globally, 5.7 million Americans live with HF and approximately half of all HF patients are women.  Heart failure affects about 2.5 million women in the United States. There are ~700,000 new cases each year. When women and men with HF are compared, there are significant differences in disease etiology, expression, outcomes, and perhaps, response to therapy.   Additionally, there have been many studies done in recent years that show that HF varies by race/ethnicity.  Many women who develop HF are misdiagnosed early on, especially younger people.  Women say their complaints may also be dismissed as symptoms of menopause, panic attack or stress.  Often, the first symptoms of HF are attributed to overwork, stress and general fatigue, rather than to a serious heart condition.  So early and accurate diagnosis are key.   Depression is frequently associated with heart failure and is more common in women than men. Patient and clinician education is necessary to increase awareness of these differences. 


Learner Outcomes

  1. Describe heart failure (HF) epidemiology and pathophysiology
  2. Recognize the different risk factors between men and women for HF
  3. Discuss current care disparities by gender and race for patients with HF
  4. Assess appropriate strategies for increasing guideline-based therapies for female HF patients
  5. Describe the modifiable risk factors that can influence patient's quality of life by utilizing appropriate patient education materials understanding cultural differences



Karol Watson, MD, PhD, FACC, FAHA is a consultant for Amgen and Merck.  She has research grants from the NHLBI, NIDDK, and NIH BD2K.

Kim Newlin, RN, CNS, NP-C, FPCNA is a consultant for Astra Zeneca and Medscape.


ANCC Accreditation Statement

This activity is provided by the American Association of Heart Failure Nurses (AAHFN).


The American Association of Heart Failure Nurses (AAHFN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.



Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.


Commercial Support

This activity is supported by Arbor Pharmaceuticals LLC.


Requirement for successful completion

View the recorded content in its entirety and the accreditation information below. Access the post test, successfully pass it with a minimum score of 70% and submit an evaluation and receive a certificate of completion. Participants who successfully complete this activity in its entirety will be awarded 1.75 contact hours. 

AAHFN is professionally managed by Association Headquarters Inc., a charter accredited association management company.